SCHEMBL23583270

SCHEMBL23583270

CC(C)(C)CN1CCSCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10715121 0.78 — —
SCHEMBL3659138 0.71 INMT (0.31) —
SCHEMBL21383924 0.71 POLB (0.32) —
SCHEMBL21383887 0.71 ALOX15 (0.31) —
SCHEMBL29865192 0.71 GAA (0.33) —
SCHEMBL21389203 0.70 DUT (0.39) —
SCHEMBL12228961 0.69 PIK3CD (0.53) —
SCHEMBL19449153 0.69 POLB (0.32) —
SCHEMBL19543018 0.69 BLM (0.31) —
SCHEMBL7803036 0.69 CYP3A4 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046684-B2 Compound for selectively inhibiting kinase and use thereof SHANGHAI ZHEYE BIOTECHNOLOGY LIMITED LIABILITY COMPANY (CN) 2021-06-29 — — US disclosed
Send feedback